Association between body mass index and serum concentrations of olanzapine and selective serotonin reuptake inhibitors in patients with eating disorders

Vilde Hersleth, Olav Spigset, Siri Weider, Elise Koch, Ole A. Andreassen, Stian Lydersen, Katrine Kveli Fjukstad

Open source

DOI
10.1007/s00228-026-04175-8
Published
2026-09
Container
European Journal of Clinical Pharmacology
Publisher
Springer Science and Business Media LLC
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s00228-026-04175-8,
  title = {Association between body mass index and serum concentrations of olanzapine and selective serotonin reuptake inhibitors in patients with eating disorders},
  author = {Vilde Hersleth and Olav Spigset and Siri Weider and Elise Koch and Ole A. Andreassen and Stian Lydersen and Katrine Kveli Fjukstad},
  year = {2026},
  journal = {European Journal of Clinical Pharmacology},
  doi = {10.1007/s00228-026-04175-8},
  url = {https://doi.org/10.1007/s00228-026-04175-8}
}

RIS

TY  - JOUR
TI  - Association between body mass index and serum concentrations of olanzapine and selective serotonin reuptake inhibitors in patients with eating disorders
AU  - Vilde Hersleth
AU  - Olav Spigset
AU  - Siri Weider
AU  - Elise Koch
AU  - Ole A. Andreassen
AU  - Stian Lydersen
AU  - Katrine Kveli Fjukstad
PY  - 2026
JO  - European Journal of Clinical Pharmacology
DO  - 10.1007/s00228-026-04175-8
UR  - https://doi.org/10.1007/s00228-026-04175-8
ER  - 

APA

Hersleth, V., Spigset, O., Weider, S., Koch, E., Andreassen, O. A., Lydersen, S., & Fjukstad, K. K. (2026). Association between body mass index and serum concentrations of olanzapine and selective serotonin reuptake inhibitors in patients with eating disorders. European Journal of Clinical Pharmacology. https://doi.org/10.1007/s00228-026-04175-8

Source records